ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases

Primary central nervous system non-Hodgkin’s lymphoma is a rare presentation, almost always of diffuse large B-cell type. Although there is no consensus regarding therapy for this condition, induction regimens are based on high-dose methotrexate and consolidation whole-brain radiotherapy, or, more p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ungur, Rodica, Tempescul, Adrian, Berthou, Christian, Bagacean, Cristina, Radeanu, Doinel, Muresan, Adriana, Zdrenghea, Mihnea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599053/
https://www.ncbi.nlm.nih.gov/pubmed/26491351
http://dx.doi.org/10.2147/OTT.S89358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599053/
https://www.ncbi.nlm.nih.gov/pubmed/26491351
http://dx.doi.org/10.2147/OTT.S89358

Ejemplares similares